Price (delayed)
$4.08
Market cap
$304.24M
P/E Ratio
11.33
Dividend/share
N/A
EPS
$0.36
Enterprise value
$58.62M
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides
There are no recent dividends present for OSUR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.